The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Bone Resorption

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Bone Resorption


Psychiatry related information on Bone Resorption


High impact information on Bone Resorption


Chemical compound and disease context of Bone Resorption


Biological context of Bone Resorption


Anatomical context of Bone Resorption


Gene context of Bone Resorption


Analytical, diagnostic and therapeutic context of Bone Resorption


  1. Treatment of congenital osteopetrosis with high-dose calcitriol. Key, L., Carnes, D., Cole, S., Holtrop, M., Bar-Shavit, Z., Shapiro, F., Arceci, R., Steinberg, J., Gundberg, C., Kahn, A. N. Engl. J. Med. (1984) [Pubmed]
  2. Esophagitis associated with the use of alendronate. de Groen, P.C., Lubbe, D.F., Hirsch, L.J., Daifotis, A., Stephenson, W., Freedholm, D., Pryor-Tillotson, S., Seleznick, M.J., Pinkas, H., Wang, K.K. N. Engl. J. Med. (1996) [Pubmed]
  3. Stimulation of bone resorption in vitro by synthetic transforming growth factor-alpha. Ibbotson, K.J., Twardzik, D.R., D'Souza, S.M., Hargreaves, W.R., Todaro, G.J., Mundy, G.R. Science (1985) [Pubmed]
  4. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Morinaga, T., Higashio, K., Martin, T.J., Suda, T. J. Exp. Med. (2000) [Pubmed]
  5. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. Weitzmann, M.N., Roggia, C., Toraldo, G., Weitzmann, L., Pacifici, R. J. Clin. Invest. (2002) [Pubmed]
  6. Vitamin D and genomic stability. Chatterjee, M. Mutat. Res. (2001) [Pubmed]
  7. Effect of administration of lipoprostaglandin E(1) on physical activity and bone resorption in patients with neurogenic intermittent claudication. Iwamoto, J., Takeda, T., Ichimura, S. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association. (2001) [Pubmed]
  8. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.S., Lüthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H.L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T.M., Hill, D., Pattison, W., Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R., Boyle, W.J. Cell (1997) [Pubmed]
  9. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. Berenson, J.R., Lichtenstein, A., Porter, L., Dimopoulos, M.A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M.J., Blacklock, H.A., Bell, R., Simeone, J., Reitsma, D.J., Heffernan, M., Seaman, J., Knight, R.D. N. Engl. J. Med. (1996) [Pubmed]
  10. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. Hortobagyi, G.N., Theriault, R.L., Porter, L., Blayney, D., Lipton, A., Sinoff, C., Wheeler, H., Simeone, J.F., Seaman, J., Knight, R.D. N. Engl. J. Med. (1996) [Pubmed]
  11. The bone density of female twins discordant for tobacco use. Hopper, J.L., Seeman, E. N. Engl. J. Med. (1994) [Pubmed]
  12. Use of dichloromethylene diphosphonate in metastatic bone disease. Jung, A., Chantraine, A., Donath, A., van Ouwenaller, C., Turnill, D., Mermillod, B., Kitler, M.E. N. Engl. J. Med. (1983) [Pubmed]
  13. Prostaglandin mediation of collagenase-induced bone resorption. Dowsett, M., Eastman, A.R., Easty, D.M., Easty, G.C., Powles, T.J., Neville, A.M. Nature (1976) [Pubmed]
  14. Direct resorption of bone by human monocytes. Mundy, C.R., Altman, A.J., Gondek, M.D., Bandelin, J.G. Science (1977) [Pubmed]
  15. Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Williams, R.C., Jeffcoat, M.K., Kaplan, M.L., Goldhaber, P., Johnson, H.G., Wechter, W.J. Science (1985) [Pubmed]
  16. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. Alexandersen, P., Toussaint, A., Christiansen, C., Devogelaer, J.P., Roux, C., Fechtenbaum, J., Gennari, C., Reginster, J.Y. JAMA (2001) [Pubmed]
  17. An essential role of cytosolic phospholipase A2alpha in prostaglandin E2-mediated bone resorption associated with inflammation. Miyaura, C., Inada, M., Matsumoto, C., Ohshiba, T., Uozumi, N., Shimizu, T., Ito, A. J. Exp. Med. (2003) [Pubmed]
  18. Increased bone formation in osteocalcin-deficient mice. Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., Bradley, A., Karsenty, G. Nature (1996) [Pubmed]
  19. Growth hormone and bone. Ohlsson, C., Bengtsson, B.A., Isaksson, O.G., Andreassen, T.T., Slootweg, M.C. Endocr. Rev. (1998) [Pubmed]
  20. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. Fuller, K., Owens, J.M., Jagger, C.J., Wilson, A., Moss, R., Chambers, T.J. J. Exp. Med. (1993) [Pubmed]
  21. Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. VanHouten, J.N., Dann, P., Stewart, A.F., Watson, C.J., Pollak, M., Karaplis, A.C., Wysolmerski, J.J. J. Clin. Invest. (2003) [Pubmed]
  22. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. Greenfield, E.M., Shaw, S.M., Gornik, S.A., Banks, M.A. J. Clin. Invest. (1995) [Pubmed]
  23. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., Nakamura, K., Taniguchi, T. Nature (2000) [Pubmed]
  24. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. Kameda, T., Mano, H., Yuasa, T., Mori, Y., Miyazawa, K., Shiokawa, M., Nakamaru, Y., Hiroi, E., Hiura, K., Kameda, A., Yang, N.N., Hakeda, Y., Kumegawa, M. J. Exp. Med. (1997) [Pubmed]
  25. Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. Thomson, B.M., Saklatvala, J., Chambers, T.J. J. Exp. Med. (1986) [Pubmed]
  26. Interleukin-11: a new cytokine critical for osteoclast development. Girasole, G., Passeri, G., Jilka, R.L., Manolagas, S.C. J. Clin. Invest. (1994) [Pubmed]
  27. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts. Takayanagi, H., Juji, T., Miyazaki, T., Iizuka, H., Takahashi, T., Isshiki, M., Okada, M., Tanaka, Y., Koshihara, Y., Oda, H., Kurokawa, T., Nakamura, K., Tanaka, S. J. Clin. Invest. (1999) [Pubmed]
  28. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Tanaka, S., Amling, M., Neff, L., Peyman, A., Uhlmann, E., Levy, J.B., Baron, R. Nature (1996) [Pubmed]
  29. Vav3 regulates osteoclast function and bone mass. Faccio, R., Teitelbaum, S.L., Fujikawa, K., Chappel, J., Zallone, A., Tybulewicz, V.L., Ross, F.P., Swat, W. Nat. Med. (2005) [Pubmed]
  30. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. Fuller, K., Wong, B., Fox, S., Choi, Y., Chambers, T.J. J. Exp. Med. (1998) [Pubmed]
  31. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. Niida, S., Kaku, M., Amano, H., Yoshida, H., Kataoka, H., Nishikawa, S., Tanne, K., Maeda, N., Nishikawa, S., Kodama, H. J. Exp. Med. (1999) [Pubmed]
  32. Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo. Yoneda, T., Lowe, C., Lee, C.H., Gutierrez, G., Niewolna, M., Williams, P.J., Izbicka, E., Uehara, Y., Mundy, G.R. J. Clin. Invest. (1993) [Pubmed]
  33. Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity. Hoskin, P.J., Stratford, M.R., Folkes, L.K., Regan, J., Yarnold, J.R. Lancet (2000) [Pubmed]
  34. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone. Gordon, A.H., O'Keefe, R.J., Schwarz, E.M., Rosier, R.N., Puzas, J.E. Cancer Res. (2005) [Pubmed]
  35. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data. Bendele, A., McAbee, T., Sennello, G., Frazier, J., Chlipala, E., McCabe, D. Arthritis Rheum. (1999) [Pubmed]
WikiGenes - Universities